User contributions for MKraft

08:4208:42, 12 July 2024 diff hist −1 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:4108:41, 12 July 2024 diff hist +922 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:4008:40, 12 July 2024 diff hist +647 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary

10:1110:11, 11 July 2024 diff hist +2,031 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
10:0810:08, 11 July 2024 diff hist +1,549 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
10:0410:04, 11 July 2024 diff hist +162 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
10:0210:02, 11 July 2024 diff hist +1,785 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:3309:33, 11 July 2024 diff hist −6 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:2909:29, 11 July 2024 diff hist +2,192 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:0509:05, 11 July 2024 diff hist −1 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:0409:04, 11 July 2024 diff hist 0 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:0309:03, 11 July 2024 diff hist +3,650 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
09:0209:02, 11 July 2024 diff hist +3,651 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:5908:59, 11 July 2024 diff hist +16 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:5908:59, 11 July 2024 diff hist +1 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:5808:58, 11 July 2024 diff hist +14 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:5708:57, 11 July 2024 diff hist +2,556 N Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This is the second study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, rando..."
08:5408:54, 11 July 2024 diff hist +2,562 N Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This study is the first study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind,..."
08:4908:49, 11 July 2024 diff hist −1 Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:4808:48, 11 July 2024 diff hist −3 Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
08:4808:48, 11 July 2024 diff hist +2,626 N Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies Created page with "{{Publication |Title=Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies |Topic=Cannabinoids |Author=Fallon, M T; Lux, E A; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S; Lichtman, A H; Kornyeyeva, E |Year=2017 |Journal=British Journal of Pain |DOI=https://doi.org/10.1177/2049463717710042 |Authors Abstract=Backgrou..."

11:4511:45, 10 July 2024 diff hist +18 Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary
11:0111:01, 10 July 2024 diff hist +10,926 Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary
09:5109:51, 10 July 2024 diff hist +2,269 Publication: Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary

05:0005:00, 8 July 2024 diff hist +2,843 Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary

12:1312:13, 1 July 2024 diff hist +12,364 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
11:0311:03, 1 July 2024 diff hist +1,704 N Publication: Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial Created page with "{{Publication |Title=Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial |Topic=Cannabinoids |Author=Côté, M; Trudel, M; Wang, C; Fortin, A |Year=2016 |Journal=Annals of Otology, Rhinology & Laryngology |DOI=https://doi.org/10.1177/0003489415612801 |Authors Abstract=Objectives: Patients treated for head and neck carcinomas experience a significant deterioration of their qua..." current

06:5306:53, 28 June 2024 diff hist +8,633 Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group No edit summary
05:4405:44, 28 June 2024 diff hist +9,329 Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients No edit summary
05:3805:38, 28 June 2024 diff hist +9,362 Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer No edit summary
05:2405:24, 28 June 2024 diff hist +9,923 Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial No edit summary
05:1505:15, 28 June 2024 diff hist +11,293 Uthaipaisanwong et al. (2020): Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study No edit summary

09:2409:24, 26 June 2024 diff hist +2,388 Publication: Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
08:0308:03, 26 June 2024 diff hist +1,070 Publication: Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group No edit summary current

10:2810:28, 25 June 2024 diff hist +9,172 Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study No edit summary
09:1009:10, 25 June 2024 diff hist +2,114 Publication: Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy No edit summary current
08:3408:34, 25 June 2024 diff hist +2,204 Publication: A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2) No edit summary current

10:0210:02, 24 June 2024 diff hist +2,373 Publication: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary

11:1811:18, 22 June 2024 diff hist +3,242 Publication: Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial No edit summary current
11:1511:15, 22 June 2024 diff hist +1,445 Publication: The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study No edit summary current
11:0711:07, 22 June 2024 diff hist +2,209 Publication: Lycopene in treatment of high-grade gliomas: A pilot study No edit summary
11:0611:06, 22 June 2024 diff hist +2,256 Publication: Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA No edit summary current
11:0411:04, 22 June 2024 diff hist +1,735 Publication: Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients No edit summary current
11:0311:03, 22 June 2024 diff hist +1,973 Publication: Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer No edit summary current
11:0211:02, 22 June 2024 diff hist +1,907 Publication: Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study No edit summary current
10:5310:53, 22 June 2024 diff hist +2,014 Publication: Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial No edit summary current
10:4810:48, 22 June 2024 diff hist +2,071 Publication: Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial No edit summary current
10:4310:43, 22 June 2024 diff hist +2,039 Publication: Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study No edit summary current

12 July 2024

11 July 2024

10 July 2024

8 July 2024

1 July 2024

28 June 2024

27 June 2024

26 June 2024

25 June 2024

24 June 2024

22 June 2024